Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular methylprednisolone versus placebo for temporomandibular joint arthralgia
2013-003365-34Phase 4Active
- Sponsor
- Specialisttandvårdskliniken Västmanlands sjukhus Västerås
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in temporomandibular joint arthralgia comparing Depo-Medrol intra-articular injection with Placebo intra-articular injection (2 arms). Primary endpoint: Change in pain intensity at maximal mouth opening. Started Aug 2013; status: active.
02
Drugs
methylprednisolone
03
Conditions
temporomandibular joint arthralgia
Beyond the preview
Go deeper on 2013-003365-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003365-34.